Results 261 to 270 of about 78,807 (341)

Novel Biallelic SQSTM1 Mutation Causing a Subacute‐Onset Complex Movement Disorder with Oculomotor Abnormalities

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Ana Luísa de Almeida Marcelino   +8 more
wiley   +1 more source

Development and Preliminary Validation of a Parkinsonism‐Dystonia Scale for Infants and Young Children

open access: yesMovement Disorders, EarlyView.
Abstract Background Parkinsonism in infancy is rare and is highly correlated with the presence of dystonia. Advances in treating and characterizing developmental and infantile degenerative parkinsonism have highlighted the need for a specialized assessment scale.
Roser Pons   +16 more
wiley   +1 more source

Lesion-Induced Blepharospasm: Epidemiology and Clinical Characteristics. [PDF]

open access: yesTremor Other Hyperkinet Mov (N Y)
Myller E, Halonen R, Corp DT, Joutsa J.
europepmc   +1 more source

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Fabienne Ory‐Magne   +2 more
wiley   +1 more source

Interpretable Machine Learning for Cross‐Cohort Prediction of Motor Fluctuations in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Motor fluctuations are a common complication in later stages of Parkinson's disease (PD) and significantly affect patients' quality of life. Robustly identifying risk and protective factors for this complication across distinct cohorts could lead to improved disease management.
Rebecca Ting Jiin Loo   +121 more
wiley   +1 more source

SGCE Myoclonus Dystonia: A Case Report. [PDF]

open access: yesEthiop J Health Sci
Deginet E, Tewoflos M, Abebe YN.
europepmc   +1 more source

Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B

open access: yesMovement Disorders, EarlyView.
Abstract Background Breakdown of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in basal ganglia cells through hydrolysis of diesteric bonds, primarily by PDE10A and PDE1B, is essential for normal human movement. While biallelic loss‐of‐function variants in PDE10A are known to cause hyperkinetic movement disorders, the ...
Tomer Poleg   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy